This is an international site for Glivec® (imatinib) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.
U.S. Residents
Download this convenient interactive tool to quickly assess your patients risk of KIT+GIST recurrence, based on tumor size, tumor site, and mitotic rate.
